1. Home
  2. NMG vs DCTH Comparison

NMG vs DCTH Comparison

Compare NMG & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nouveau Monde Graphite Inc.

NMG

Nouveau Monde Graphite Inc.

HOLD

Current Price

$1.30

Market Cap

414.7M

ML Signal

HOLD

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$12.85

Market Cap

398.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NMG
DCTH
Founded
2011
1988
Country
Canada
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
414.7M
398.7M
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
NMG
DCTH
Price
$1.30
$12.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$5.75
$22.00
AVG Volume (30 Days)
520.0K
332.2K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
107.53
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$24.54
Revenue Next Year
N/A
$33.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.26
$8.12
52 Week High
$6.06
$13.74

Technical Indicators

Market Signals
Indicator
NMG
DCTH
Relative Strength Index (RSI) 37.81 56.62
Support Level $1.26 $9.98
Resistance Level $1.67 $13.74
Average True Range (ATR) 0.08 0.50
MACD 0.00 -0.08
Stochastic Oscillator 18.33 74.30

Price Performance

Historical Comparison
NMG
DCTH

About NMG Nouveau Monde Graphite Inc.

Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The Company currently operates in two segments: the Mining projects (which includes the Matawinie Mine project and the Uatnan Mining Project) and the Battery Material Plant project.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: